🧑‍🏫Introduce

UBT Product Introduce

With the advancement of biotechnology and the growth of the market, investments and transactions are becoming increasingly active across borders. Especially after the COVID-19 pandemic, investments in biotechnology have been on the rise. However, accessibility and transparency in this market are still not as efficient as desired. The introduction of blockchain technology appears to be a necessary solution to address these challenges. UBT is emerging as a new platform for the biotechnology market in response to these demands.

Biotechnology plays a crucial role in enhancing human life and welfare in modern society. However, to realize such value, investments and transactions need to be conducted more transparently and efficiently. Blockchain technology offers new possibilities for the biotechnology market, and UBT aims to establish a decentralized platform to capitalize on this. Through the integration of biotechnology and blockchain technology via UBT tokens, various businesses in the biotechnology field will be applied. The UBT token, serving as the core token within the UBT ecosystem, will provide a new platform for trading the value of biotechnology in the market.

  1. Core Technology:

  • Possession of standardized raw materials using Seapolynol

  • Production of pharmaceutical-grade standardized raw materials utilizing Seapolynol composed of 14 ingredients extracted from Ecklonia cava

  1. Competitiveness:

  • Building competitiveness through the product line with food and pharmaceutical applicability, gaining industry attention

  1. Business Expansion:

  • Expansion plan for a new concept leading & rewarding healthcare platform combined with blockchain

  1. Business Strategy:

  • Implementation of prevention and prescription algorithms through collaboration with medical devices, diagnostic devices, pharmaceuticals, and health supplements worldwide

  • Building a leading/reward healthcare platform that can maximize user health and revenue at the same time

  1. Partnerships:

  • about 50 patents for natural products

  • 130 SCI-class papers published

  • Hold certification data from international authorities

  • Have enough value to enter the global market

With these features, UBT aims to take a leading position in the field of biotechnology healthcare.

PreviousBusiness ModelNextEffect

Last updated